In addition to pH, ion, voltage and temperature measurement, the combined 781 pH/Ion Meter also offers an automatic stirrer control, a multi-point calibration with up to nine buffers (pH mode), a ...

Together with David Tabaczynski (an entrepreneur from Boston) and QUBIS, McCarthy spun out her drug delivery technology in May this year into Phion Therapeutics. Through 11 years of research with ...

The transaction supports invoX’s strategy to be a fully integrated biopharmaceutical company and its ongoing commitment to deliver innovative life-saving therapies pHion is developing a pipeline ...

SAN FRANCISCO--(BUSINESS WIRE)--Numbase Group founder and Chairman Ayman Zakaria Jomaa has been elected to serve on the board of directors of PHION Technologies, a company specializing in over-the ...

Austrian network security vendor Phion is hunting for its first UK resellers as part of a European expansion drive. Phion already claims to be the fourth largest network security vendor in central ...

Belfast-based Phion Therapeutics has won the main prize at this year's InterTradeIreland Seedcorn competition. Phion has developed a new drug delivery system which it licenses to pharmaceutical ...

Phion Therapeutics was set up in May at Queen’s University by Professor Helen McCarthy and David Tabaczynski, mainly based on intellectual property developed at the School of Pharmacy.

21,224 shares of phion AG. Furthermore, phion AG announces that it was informed by Barracuda Networks, Inc. that, following the acquisition of these 21,224 shares, Barracuda Networks, Inc. holds ...

The transaction supports invoX’s strategy to be a fully integrated biopharmaceutical company and its ongoing commitment to deliver innovative life-saving therapies pHion is developing a pipeline of ...

invoX Pharma has made a second tranche of investment in pHion Therapeutics to support further development of next-generation mRNA vaccines. invoX Pharma, a UK-based wholly owned subsidiary of ...

Investment will enable pHion to progress its lead program into the clinic Transaction builds on invoX's initial investment in 2021 invoX Pharma Limited ("invoX")a U.K.-based wholly-owned ...